T1	PROC 515 526	Tratamiento
#1	AnnotatorNotes T1	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T2	DISO 1298 1310	esferofaquia
#2	AnnotatorNotes T2	C0266542; Spherophakia; Congenital Abnormality
T3	DISO 126 140	corto de vista
#3	AnnotatorNotes T3	C0027092; Myopia; Disease or Syndrome
T4	CHEM 179 187	atropina
#4	AnnotatorNotes T4	C0004259; atropine; Organic Chemical · Pharmacologic Substance
T5	ANAT 204 208	ojos
#5	AnnotatorNotes T5	C0015392; Eye; Body Part, Organ, or Organ Component | C1280202; Entire eye; Body Part, Organ, or Organ Component
T6	PROC 211 218	placebo
#6	AnnotatorNotes T6	C0032042; Placebos; Therapeutic or Preventive Procedure
T7	CHEM 262 270	Atropina
#7	AnnotatorNotes T7	C0004259; atropine; Organic Chemical · Pharmacologic Substance
T8	DISO 296 302	miopía
#8	AnnotatorNotes T8	C0027092; Myopia; Disease or Syndrome
T9	PROC 324 422	estudio de fase 3 con tres grupos, aleatorizado, con doble enmascaramiento, controlado con placebo
T10	DISO 558 564	miopía
#9	AnnotatorNotes T10	C0027092; Myopia; Disease or Syndrome
T11	CHEM 456 472	atropina sulfato
#10	AnnotatorNotes T11	C0596005; atropine sulfate; Organic Chemical · Pharmacologic Substance
T12	DISO 570 584	corto de vista
#11	AnnotatorNotes T12	C0027092; Myopia; Disease or Syndrome
T13	DISO 638 644	miopía
#12	AnnotatorNotes T13	C0027092; Myopia; Disease or Syndrome
T14	DISO 725 731	Miopía
#13	AnnotatorNotes T14	C0027092; Myopia; Disease or Syndrome
T15	DISO 783 789	miopía
#14	AnnotatorNotes T15	C0027092; Myopia; Disease or Syndrome
T16	DISO 898 910	astigmatismo
#15	AnnotatorNotes T16	C0004106; Astigmatism; Disease or Syndrome
T17	ANAT 937 940	ojo
#16	AnnotatorNotes T17	C0015392; Eye; Body Part, Organ, or Organ Component | C1280202; Entire eye; Body Part, Organ, or Organ Component
T18	DISO 972 981	ambliopía
#17	AnnotatorNotes T18	C0002418; Amblyopia; Disease or Syndrome
T19	DISO 984 994	estrabismo
#18	AnnotatorNotes T19	C0038379; Strabismus; Disease or Syndrome
T20	DISO 1036 1046	enfermedad
#19	AnnotatorNotes T20	C0012634; Disease; Disease or Syndrome
T21	DISO 1049 1057	síndrome
#20	AnnotatorNotes T21	C0039082; Syndrome; Disease or Syndrome
T22	DISO 1090 1096	miopía
#21	AnnotatorNotes T22	C0027092; Myopia; Disease or Syndrome
T23	DISO 1111 1129	Síndrome de Marfan
#22	AnnotatorNotes T23	C0024796; Marfan Syndrome; Disease or Syndrome
T24	DISO 1131 1151	síndrome de Stickler
#23	AnnotatorNotes T24	C0265253; Stickler syndrome (disorder); Disease or Syndrome
T25	DISO 1153 1183	retinopatía de la prematuridad
#24	AnnotatorNotes T25	C0035344; Retinopathy of Prematurity; Disease or Syndrome
T26	ANAT 1223 1227	ojos
#25	AnnotatorNotes T26	C0015392; Eye; Body Part, Organ, or Organ Component | C1280202; Entire eye; Body Part, Organ, or Organ Component
T27	ANAT 1251 1257	ocular
#26	AnnotatorNotes T27	C0015392; Eye; Body Part, Organ, or Organ Component | C1280202; Entire eye; Body Part, Organ, or Organ Component
T28	DISO 1274 1285	queratocono
#27	AnnotatorNotes T28	C0022578; Keratoconus; Disease or Syndrome
T29	DISO 1287 1296	lenticono
#28	AnnotatorNotes T29	C0239119; Lenticonus; Congenital Abnormality
T30	DISO 1316 1336	Enfermedad sistémica
#29	AnnotatorNotes T30	C0442893; Systemic disease; Disease or Syndrome
T31	CHEM 1475 1496	medicamento oftálmico
#30	AnnotatorNotes T31	C0304650; ophthalmic preparation; Pharmacologic Substance
T32	PROC 1515 1521	receta
#31	AnnotatorNotes T32	C0033080; Prescription procedure; Health Care Activity | C2239117; Prescription of drug (procedure); Health Care Activity
T33	CHEM 1537 1548	medicamento
#32	AnnotatorNotes T33	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T34	CHEM 230 238	atropina
#33	AnnotatorNotes T34	C0004259; atropine; Organic Chemical · Pharmacologic Substance
T35	ANAT 798 801	ojo
#34	AnnotatorNotes T35	C0015392; Eye; Body Part, Organ, or Organ Component | C1280202; Entire eye; Body Part, Organ, or Organ Component
T36	PROC 818 846	autorrefracción ciclopléjica
#35	AnnotatorNotes T36	C2163798; cycloplegic refraction using autorefraction; Diagnostic Procedure
T37	DISO 1231 1265	anatomía refractiva ocular anormal
T38	DISO 114 120	miopía
#36	AnnotatorNotes T38	C0027092; Myopia; Disease or Syndrome
T39	Date 13 17	2018
T40	LIVB 145 150	niños
#37	AnnotatorNotes T40	C0008059; Child; Age Group
T41	Form 191 196	gotas
#38	AnnotatorNotes T41	C0015399; Eye Drops; Biomedical or Dental Material
T42	Form 220 225	gotas
#39	AnnotatorNotes T42	C0015399; Eye Drops; Biomedical or Dental Material
T43	Neg_cue 226 229	sin
T44	LIVB 306 311	niños
#40	AnnotatorNotes T44	C0008059; Child; Age Group
T45	Form 434 452	solución oftálmica
T46	Dose 473 481	al 0,01%
T47	LIVB 589 594	niños
#41	AnnotatorNotes T47	C0008059; Child; Age Group
T48	LIVB 674 679	Niños
#42	AnnotatorNotes T48	C0008059; Child; Age Group | C0870221; Boys; Age Group
T49	LIVB 682 687	niñas
#43	AnnotatorNotes T49	C0008059; Child; Age Group | C0870604; Female child; Age Group
T51	LIVB 1077 1083	sujeto
#44	AnnotatorNotes T51	C0681850; Study Subject; Group
T52	LIVB 1370 1382	investigador
#45	AnnotatorNotes T52	C0035173; Research Personnel; Professional or Occupational Group
T54	LIVB 1402 1408	sujeto
#46	AnnotatorNotes T54	C0681850; Study Subject; Group
T55	Duration 1426 1433	crónico
#47	AnnotatorNotes T55	C0205191; chronic; Temporal Concept
T56	Frequency 1435 1460	más de 3 días a la semana
T57	Route 1497 1503	tópico
#48	AnnotatorNotes T57	C1522168; Topical Route of Drug Administration; Functional Concept
T58	Neg_cue 1511 1514	sin
T59	Neg_cue 1527 1529	no
T60	PHYS 135 140	vista
#49	AnnotatorNotes T60	C0042789; Vision; Organism Function
T61	PHYS 579 584	vista
#50	AnnotatorNotes T61	C0042789; Vision; Organism Function
T62	Dose 484 489	0,02%
T63	Dose 160 175	dosis muy bajas
T64	Age 691 712	entre 3 y = 17,0 años
A1	Population_data T40 Age
A2	Assertion T34 Negated
A4	Population_data T47 Age
A5	Population_data T49 Age
A6	Population_data T48 Age
A7	Assertion T32 Negated
A8	Assertion T33 Negated
A3	Population_data T44 Age
A9	Status T18 History_of
A10	Status T20 History_of
A11	Status T21 History_of
A12	Status T37 History_of
A13	Status T28 History_of
A14	Status T29 History_of
A15	Status T2 History_of
A16	Status T23 History_of
A17	Status T24 History_of
A18	Status T25 History_of
#51	AnnotatorNotes T45	C0029083; Ophthalmic Solution; Biomedical or Dental Material
T50	Observation 1413 1417	apto
A19	Assertion T50 Negated
#52	AnnotatorNotes T50	C1302261; Patient eligible for clinical trial; Finding (?)
T53	Neg_cue 1384 1386	no
T65	Result_or_Value 761 779	superior a -6,00 D
A20	Assertion T65 Negated
T66	Neg_cue 758 760	no
T67	Result_or_Value 739 755	al menos -0,50 D
T68	Observation 80 90	progresión
#53	AnnotatorNotes T68	C1457868; Worse; Finding (?)
T69	Observation 92 106	emperoramiento
#54	AnnotatorNotes T69	C1457868; Worse; Finding (?)
R1	Before Arg1:T38 Arg2:T69	
R2	Before Arg1:T38 Arg2:T68	
R3	Before Arg1:T3 Arg2:T69	
R4	Before Arg1:T3 Arg2:T68	
R9	Experiences Arg1:T40 Arg2:T68	
R10	Experiences Arg1:T40 Arg2:T69	
R11	Experiences Arg1:T40 Arg2:T38	
R12	Experiences Arg1:T40 Arg2:T3	
R13	Experiences Arg1:T40 Arg2:T60	
R14	Experiences Arg1:T40 Arg2:T4	
R15	Has_Dose_or_Strength Arg1:T4 Arg2:T63	
R16	Has_Drug_Form Arg1:T4 Arg2:T41	
R17	Location_of Arg1:T5 Arg2:T4	
R18	Location_of Arg1:T5 Arg2:T38	
R19	Location_of Arg1:T5 Arg2:T3	
R20	Location_of Arg1:T5 Arg2:T60	
R21	Experiences Arg1:T40 Arg2:T6	
R22	Has_Drug_Form Arg1:T34 Arg2:T42	
R23	Negation Arg1:T43 Arg2:T34	
R24	Location_of Arg1:T5 Arg2:T6	
R25	Has_Drug_Form Arg1:T6 Arg2:T42	
R26	Experiences Arg1:T44 Arg2:T7	
R27	Experiences Arg1:T44 Arg2:T8	
T71	Observation 279 289	progresión
#56	AnnotatorNotes T71	C1457868; Worse; Finding (?)
R28	Before Arg1:T8 Arg2:T71	
R29	Experiences Arg1:T44 Arg2:T71	
R30	Experiences Arg1:T44 Arg2:T11	
R31	Has_Dose_or_Strength Arg1:T11 Arg2:T46	
R32	Has_Dose_or_Strength Arg1:T11 Arg2:T62	
R33	Has_Drug_Form Arg1:T11 Arg2:T45	
R34	Has_Drug_Form Arg1:T7 Arg2:T45	
R35	Has_Dose_or_Strength Arg1:T7 Arg2:T46	
R36	Has_Dose_or_Strength Arg1:T7 Arg2:T62	
R37	Experiences Arg1:T47 Arg2:T61	
R38	Experiences Arg1:T47 Arg2:T12	
R39	Experiences Arg1:T47 Arg2:T10	
R40	Experiences Arg1:T47 Arg2:T1	
T73	Observation 541 551	progresión
#58	AnnotatorNotes T73	C1457868; Worse; Finding (?)
R43	Before Arg1:T10 Arg2:T73	
R44	Experiences Arg1:T47 Arg2:T73	
R48	Has_Age Arg1:T49 Arg2:T64	
R49	Has_Age Arg1:T48 Arg2:T64	
R50	Has_Result_or_Value Arg1:T14 Arg2:T67	
R51	Negation Arg1:T66 Arg2:T65	
R52	Location_of Arg1:T35 Arg2:T15	
R53	Location_of Arg1:T35 Arg2:T14	
R54	Has_Result_or_Value Arg1:T15 Arg2:T67	
R55	Has_Result_or_Value Arg1:T14 Arg2:T65	
R56	Has_Result_or_Value Arg1:T15 Arg2:T65	
R57	Location_of Arg1:T35 Arg2:T36	
R58	Location_of Arg1:T17 Arg2:T16	
T74	Result_or_Value 914 927	maás de -1.50
R59	Has_Result_or_Value Arg1:T16 Arg2:T74	
R60	Experiences Arg1:T51 Arg2:T20	
R61	Experiences Arg1:T51 Arg2:T21	
R62	Before Arg1:T21 Arg2:T22	
R63	Before Arg1:T20 Arg2:T22	
R64	Before Arg1:T23 Arg2:T22	
R65	Before Arg1:T24 Arg2:T22	
R66	Before Arg1:T25 Arg2:T22	
T75	Quantifier_or_Qualifier 1097 1102	grave
#59	AnnotatorNotes T75	C1547227; Severe - Severity of Illness Code; Intellectual Product
R67	Has_Quantifier_or_Qualifier Arg1:T22 Arg2:T75	
R68	Experiences Arg1:T51 Arg2:T22	
R69	Experiences Arg1:T51 Arg2:T23	
R70	Experiences Arg1:T51 Arg2:T24	
R71	Experiences Arg1:T51 Arg2:T25	
R72	Location_of Arg1:T26 Arg2:T37	
R73	Location_of Arg1:T27 Arg2:T37	
R74	Location_of Arg1:T26 Arg2:T28	
R75	Location_of Arg1:T26 Arg2:T29	
R76	Location_of Arg1:T26 Arg2:T2	
R77	Location_of Arg1:T27 Arg2:T28	
R78	Location_of Arg1:T27 Arg2:T29	
R79	Location_of Arg1:T27 Arg2:T2	
T76	Quantifier_or_Qualifier 1337 1342	grave
#60	AnnotatorNotes T76	C1547227; Severe - Severity of Illness Code; Intellectual Product
R80	Has_Quantifier_or_Qualifier Arg1:T30 Arg2:T76	
R81	Before Arg1:T30 Arg2:T50	
R82	Has_Quantifier_or_Qualifier Arg1:T54 Arg2:T50	
R83	Experiences Arg1:T54 Arg2:T30	
R84	Negation Arg1:T53 Arg2:T50	
R85	Has_Duration_or_Interval Arg1:T31 Arg2:T55	
R86	Has_Frequency Arg1:T31 Arg2:T56	
R87	Has_Route_or_Mode Arg1:T31 Arg2:T57	
R88	Negation Arg1:T58 Arg2:T32	
R90	Negation Arg1:T59 Arg2:T33	
T77	Quantifier_or_Qualifier 1549 1557	asignado
A21	Assertion T77 Negated
R91	Has_Quantifier_or_Qualifier Arg1:T33 Arg2:T77	
R92	Negation Arg1:T59 Arg2:T77	
T78	Observation 621 631	Progresión
#61	AnnotatorNotes T78	C1457868; Worse; Finding (?)
R93	Before Arg1:T13 Arg2:T78	
T79	Route 1487 1496	oftálmico
#62	AnnotatorNotes T79	C1522230; Ophthalmic Route of Drug Administration; Functional Concept
R94	Has_Route_or_Mode Arg1:T31 Arg2:T79	
R5	Before Arg1:T12 Arg2:T73	
A22	Status T19 History_of
R7	Used_for Arg1:T34 Arg2:T6	
A23	Experiencer T47 Patient
A24	Experiencer T44 Patient
A25	Experiencer T40 Patient
A26	Experiencer T49 Patient
A27	Experiencer T48 Patient
A28	Assertion T16 Hypothetical
A29	Experiencer T51 Patient
A30	Experiencer T52 Other
A31	Experiencer T54 Patient
